Penser by Carnegie acts as joint bookrunner in the partially guaranteed rights rights issue of SEK 134.9 million.
Dicot Pharma is developing the drug candidate LIB-01, which will be a potency agent to better treat erectile dysfunction and premature ejaculation. The ambition is to create a drug with significantly longer effect and far fewer side effects, compared to current available drugs.